3 new compounds discovered by domestic drug companies are on the clinical phase III studies, showing its commercialization very soon.
The KFDA said that 3 new drugs included Apitoxin inj. (Kuju) for the treatment of osteoarthritis, Yuvax III inj. (LG chemical) and Q-35 (Choongwe), a Quinolone anti-bacterial agent.
In the meantime DA-125 (Dong-A), an Anthracycline anti-cancer drug and CKD-...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.